Thinks 1100

WSJ reviews Roma Agrawal’s new book: ““Nuts & Bolts” riffs on the classic list of simple machines you might recall from grade school. These six devices—the lever, pulley, inclined plane, wedge, screw and wheel—revolutionized human life by allowing people to overcome otherwise insurmountable forces and get back far greater returns of work for a given input. While acknowledging the importance of the canonical six, Ms. Agrawal points out that they were first identified as such in the Renaissance, and feel “outdated and insufficient” today. So she’s devised her own updated list, dividing “Nuts & Bolts” into seven chapters, each focusing on one of the simple machines that drive the world today—the lens, magnet, nail, pump, spring and string, along with the classic wheel.”

NYTimes: “We are witnessing the dark side of our new technological lives, whose extractive profit models amount to the systematic fracking of human beings: pumping vast quantities of high-pressure media content into our faces to force up a spume of the vaporous and intimate stuff called attention, which now trades on the open market. Increasingly powerful systems seek to ensure that our attention is never truly ours…The moment has come for a new and parallel revolution against the dishonest expropriation of value from you and me and, most visibly of all, our children. We need a new kind of resistance, equal to the little satanic mills that live in our pockets. This is going to require attention to attention, and dedicated spaces to learn (or relearn) the powers of this precious faculty. Spaces where we can give our focus to objects and language and other people, and thereby fashion ourselves in relation to a common world. If you think that this sounds like school, you’re right: This revolution starts in our classrooms. We must flip the script on teachers’ perennial complaint. Instead of fretting that students’ flagging attention doesn’t serve education, we must make attention itself the thing being taught.”

Andy Kessler on magic pills: “Could there be magic cures? History shows plenty of wonder drugs and treatments. Aspirin reduces inflammation. Penicillin and other antibiotics fight infections. Insulin treats diabetes. Stents unblock arteries. These treat but don’t cure diseases. Plus, two-thirds of American adults are overweight or obese, which puts them at greater risk for many chronic diseases such as heart disease and stroke. According to the National Institutes of Health, “86% of health care costs are attributable to chronic disease.” By now you’ve heard about glucagon-like peptides (GLP-1). Drugs that mimic these hormones, like Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro, seem to treat diabetes by lowering blood-sugar levels. They also promote weight loss and lower the risk of heart disease. What can’t GLP-1s do?…Technology is changing medicine. Maybe there is a magic pill after all.”

Cal Henderson: “Apart from search and summarisation and being able to harness large amounts of knowledge, I think there’s a lot of interesting opportunities that are helping people write software better. It’s still very early days, we are not quite a year into ChatGPT being released, which changed how the world was thinking about AI. And we’re really just starting to see the first actual large-scale products get into the market. So I think almost every kind of information worker role is going to be augmented by AI in some way over the next couple of years. And we’re really just starting to scratch the surface. Of course, because these tools are being built by software engineers, software engineering is the first area that’s augmented by it. But I think we’re going to continue to see it across a wide variety of disciplines of taking some portion of that work, and being able to automate it, make it faster or accurate, and leave time for the higher leverage work.”

Arnold Kling: “The political appeal of public provision of goods and services is that the recipients have the illusion of a free lunch.” [via CafeHayek]

Published by

Rajesh Jain

An Entrepreneur based in Mumbai, India.